STOCK TITAN

Usana Health Sciences Inc Stock Price, News & Analysis

USNA NYSE

Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.

USANA Health Sciences, Inc. (NYSE: USNA) is a global nutrition company that develops and manufactures nutritional supplements, functional foods, personal care products, skincare, and healthy living products. This news page aggregates coverage of USANA’s announcements, giving readers a focused view of how the company communicates about its business, products, and strategic priorities.

Investors and observers can use this page to follow USANA’s updates on net sales outlooks, segment performance, and guidance, as reflected in press releases tied to events such as investor conferences and quarterly results. The company issues news on its direct selling operations, its Hiya direct-to-consumer segment, and its Rise Wellness business, including commentary on growth expectations, investments in inventory and capital expenditures, and integration initiatives.

USANA also publishes product-focused news, such as third-party certifications for its Probiotic and MagneCal D supplements, which have earned the ConsumerLab.com Seal of Approval. These items highlight the company’s emphasis on purity, potency, and scientific standards for its nutritional products. Additional stories cover partnerships, including its collaboration with the Jamaica Bobsleigh and Skeleton Federation, and community initiatives led by the USANA Foundation to address food insecurity.

Leadership and culture are recurring themes in USANA’s communications, with messages from its Executive Chairman and CEO on growth mindset, values-based leadership, and social wellness. By visiting this page regularly, readers can track how USANA presents its strategy, product quality, philanthropy, and international footprint through official news releases.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
-
Rhea-AI Summary

USANA Health Sciences, Inc. (NYSE: USNA) reported financial results for the first quarter of fiscal 2023, ending April 1, 2023. Net sales reached $248 million, down 9% from $273 million in Q1 2022 but an increase of 9% from the previous quarter. Diluted earnings per share (EPS) were $0.95, a 44% increase from $0.66 in Q4 2022, though a 17% decline compared to $1.15 in Q1 2022. The company generated $13 million in operating cash flow and ended the quarter with $295 million in cash, remaining debt-free. USANA raised its fiscal 2023 guidance for net sales to $875 to $950 million and diluted EPS to $2.40 to $3.30, reflecting strong early quarter performance driven by demand in China and proactive measures like product price increases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.45%
Tags
none
Rhea-AI Summary

USANA Health Sciences (NYSE: USNA) earned two awards at the 2023 Korea Medical Healthcare Awards, held on April 20, 2023, in Seoul. Recognized for its HealthPak in the multivitamin category and Nutrimeal Active in the food weight-management category, these accolades highlight USANA's commitment to innovative health solutions.

For five consecutive years, HealthPak has been awarded for its comprehensive nutrient profile, including 14 vitamins, 9 minerals, and 7 botanicals, promoting cellular health. Nutrimeal Active also won recognition for the third year, offering a balanced meal option rich in protein and low in sugar.

The awards reflect USANA’s ongoing dedication to providing quality nutritional products, with plans to maintain its leadership position in the health industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
none
-
Rhea-AI Summary

USANA Health Sciences, Inc. (NYSE:USNA) announced its first quarter results will be released after market close on April 25, 2023. Following this, a Management Commentary document will be available on the company's Investor Relations website. An analyst conference call is scheduled for April 26, 2023, at 11:00 a.m. Eastern Time, which will be broadcast online. USANA specializes in the development and manufacturing of high-quality nutritional supplements, healthy foods, and personal care products sold primarily in markets including the United States, Canada, Australia, and Hong Kong. More information is accessible at USANA's Investor Relations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.7%
Tags
conferences earnings
-
Rhea-AI Summary

On April 3, 2023, Kevin Guest, CEO of USANA Health Sciences (NYSE: USNA), celebrates International Guitar Month by advocating for harmony in life through music. Guest, a musician and author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony, emphasizes the productivity and happiness that comes from living in alignment with core values. He cites five benefits of music: reduced stress, improved mood, better sleep, increased concentration, and enhanced creativity. Each book sold provides 40 meals to hungry children, reinforcing USANA's commitment to social responsibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.81%
Tags
none
Rhea-AI Summary

USANA Hong Kong Receives Recognition from Euromonitor International

On March 29, 2023, USANA Hong Kong was named the top brand for calcium supplements by Euromonitor International. The accolade is based on retail value sales data for USANA’s MagneCal D supplement, highlighting its strong market performance. Regional VP Vivienne Lee expressed gratitude for customer support, emphasizing the company's commitment to quality. Philip Tang, general manager, noted this award reflects USANA's vision of promoting health. The recognition positions USANA favorably in the competitive nutritional supplement sector in Hong Kong.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.02%
Tags
none

FAQ

What is the current stock price of Usana Health Sciences (USNA)?

The current stock price of Usana Health Sciences (USNA) is $17.34 as of March 13, 2026.

What is the market cap of Usana Health Sciences (USNA)?

The market cap of Usana Health Sciences (USNA) is approximately 314.6M.

USNA Rankings

USNA Stock Data

314.61M
10.39M
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY

USNA RSS Feed